Applying the 2005 Caprini Score to Plastic Surgery Patients: A Quality Improvement Project.

Annals of plastic surgery 2023 Vol.90(6S Suppl 5) p. S617-S621

Dahmus ES, Westfall-Snyder J, Schroer J, Wang S, Kauffman CA, DeSantis J, Devitt S

관련 도메인

Abstract

[BACKGROUND] The Caprini score is a validated scale that calculates a patient's 30-day venous thromboembolism (VTE) risk based on their comorbidities. The American Society of Plastic Surgeons published VTE prophylaxis recommendations in 2011 based on the Caprini score, but these recommendations are vague and up to physician interpretation. The purpose of this study is to evaluate postoperative outcomes after the application of strict guidelines using the Caprini score with specific VTE chemoprophylaxis benchmarks on plastic surgery patients.

[METHODS] A retrospective cohort analysis was performed on all plastic surgery patients who underwent surgery between July 2019 and July 2021. Patients between July 2019 and June 2020 were not subjected to any specific VTE prophylaxis protocol, while patients from July 2020 to July 2021 were subjected to the newly created VTE prophylaxis protocol. Every patient received a calculated Caprini score at their preoperative history and physical. The primary outcomes measured include hematoma, deep vein thrombosis (DVT) and pulmonary embolism (PE).

[RESULTS] Four hundred forty-one patients with 541 procedures were included in this study, with 275 patients in the "before" group and 166 patients in the "after" group. A total of 78.6% of patients received chemoprophylaxis in the "before" group compared with 20% in the "after" group. There was no significant difference in postoperative complications between the two groups including PE or DVT ( P = 0.2684 and 0.2696, respectively), with a trend toward hematoma formation in the "before" group ( P = 0.1358). After the application of evidence-based VTE guidelines, the patients stayed fewer days in the hospital (0.4 vs 0.7 days, P = 0.0085) and were less likely to be readmitted (2.4% vs 6.5%, P = 0.0333). The average cost per patient in the "before" group was $9.11 with a total cost of $3022.90. The average cost per patient in the "after" group was $4.23 with a total cost of $867.94 ( P = 0.032).

[CONCLUSIONS] Our strict application of the Caprini score significantly and safely limited the number of patients receiving postoperative VTE chemoprophylaxis and showed no significant difference in postoperative hematoma, DVT, or PE.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
합병증 hematoma 혈종 dict 3
해부 pulmonary scispacy 1
합병증 DVT → deep vein thrombosis scispacy 1
약물 [BACKGROUND] scispacy 1
약물 [RESULTS] Four scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 venous thromboembolism C1861172
Venous Thromboembolism
scispacy 1
질환 VTE → venous thromboembolism C1861172
Venous Thromboembolism
scispacy 1
질환 vein thrombosis C0042487
Venous Thrombosis
scispacy 1
질환 DVT → deep vein thrombosis C0149871
Deep Vein Thrombosis
scispacy 1
질환 pulmonary embolism C0034065
Pulmonary Embolism
scispacy 1
질환 postoperative hematoma C0338380
Postoperative hematoma
scispacy 1
기타 Patients scispacy 1
기타 patient scispacy 1
기타 venous scispacy 1

MeSH Terms

Humans; Venous Thromboembolism; Retrospective Studies; Surgery, Plastic; Risk Assessment; Quality Improvement; Pulmonary Embolism; Postoperative Complications; Risk Factors; Anticoagulants

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문